All Curated Mutation Sites in HBV

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HBV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Show All

BCP

Core Promoter

Core Upstream Regulatory Sequence

Keyword: Core Upstream Regulatory Sequence

ID	PMID	Mutation	Gene/Protein/Region	Disease	Description	Detail
1	31269905	A1762T	Core Upstream Regulatory Sequence	Occult HBV Infection	G L	View
2	31269905	G1727A	Core Upstream Regulatory Sequence	Occult HBV Infection	G L	View
3	31269905	G1727C	Core Upstream Regulatory Sequence	Occult HBV Infection	G L	View
4	31269905	G1764A	Core Upstream Regulatory Sequence	Occult HBV Infection	G L	View
5	31269905	T1727A	Core Upstream Regulatory Sequence	Occult HBV Infection	G L	View
6	31269905	T1727C	Core Upstream Regulatory Sequence	Occult HBV Infection	G L	View
7	22997074	T1678C	Core Upstream Regulatory Sequence	Hepatitis B, Chronic	G R S C L	View
8	22997074	A1652G	Core Upstream Regulatory Sequence	Hepatitis B, Chronic	G R S C L	View
9	22997074	A1679C	Core Upstream Regulatory Sequence	Hepatitis B, Chronic	G R S C L	View
10	22997074	A1679G	Core Upstream Regulatory Sequence	Hepatitis B, Chronic	G R S C L	View
11	22997074	A1703T	Core Upstream Regulatory Sequence	Hepatitis B, Chronic	G R S C L	View
12	22997074	T1678G	Core Upstream Regulatory Sequence	Hepatitis B, Chronic	G R S C L	View

Contents
Description

The table shows all curated mutation sites of HBV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.